GCM
LLY icon

Gallacher Capital Management’s Eli Lilly LLY Stock Holding History

Gallacher Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$638K Sell
532
-92
-15% -$94K 0.36% 68
2026
Q1 		$574K Sell
624
-931
-60% -$944K 0.22% 135
2025
Q4 		$1.67M Buy
1,555
+61
+4% +$58.3K 0.65% 29
2025
Q3 		$1.14M Buy
1,494
+698
+88% +$519K 0.45% 41
2025
Q2 		$621K Buy
796
+317
+66% +$246K 0.29% 85
2025
Q1 		$396K Buy
479
+92
+24% +$76.6K 0.19% 153
2024
Q4 		$299K Sell
387
-28
-7% -$23.2K 0.15% 194
2024
Q3 		$368K Sell
415
-6
-1% -$5.39K 0.17% 158
2024
Q2 		$381K Hold
421
– – 0.2% 141
2024
Q1 		$327K Sell
421
-1
-0.2% -$712 0.17% 174
2023
Q4 		$246K Sell
422
-4
-0.9% -$2.33K 0.14% 207
2023
Q3 		$229K Sell
426
-4
-0.9% -$2.06K 0.14% 196
2023
Q2 		$202K Sell
430
-161
-27% -$67.5K 0.12% 232
2023
Q1 		$203K Buy
+591
New +$199K 0.12% 228

Other funds holding LLY

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

Gallacher Capital Management's LLY Position: Q2 2026 in Review

Gallacher Capital Management reduced its Eli Lilly (LLY) stake by 15% in Q2 2026, selling an estimated $94K and leaving 532 shares worth $638K. The position accounts for 0.36% of the portfolio, ranked #68.

Gallacher Capital Management first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.67M in Q4 2025. 1,233 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Gallacher Capital Management held 532 shares of Eli Lilly worth $638K as of Q2 2026.
  • Gallacher Capital Management sold 92 Eli Lilly shares in Q2 2026, an estimated $94K.
  • Eli Lilly made up 0.36% of Gallacher Capital Management's portfolio in Q2 2026, its #68 holding.
  • Gallacher Capital Management first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • Gallacher Capital Management's Eli Lilly position peaked at $1.67M in Q4 2025.
  • 1,233 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.